{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:21:41Z","timestamp":1790292101532,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.biopha.2017.07.129","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:30:21Z","timestamp":1501547421000},"page":"362-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats"],"prefix":"10.1016","volume":"94","author":[{"given":"Azza I.","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh R.","family":"El-Sawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"El-Missiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Abukhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.07.129_bib0005","series-title":"Anthocyanins and Human Health: Biomolecular and Therapeutic Aspects","author":"Haq","year":"2016"},{"key":"10.1016\/j.biopha.2017.07.129_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2017.07.129_bib0015","doi-asserted-by":"crossref","first-page":"e78330","DOI":"10.1371\/journal.pone.0078330","article-title":"Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms","volume":"8","author":"Picatoste","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.07.129_bib0020","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","article-title":"Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy","volume":"48","author":"Cai","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12967-014-0364-1","article-title":"(Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response","volume":"13","author":"Khanra","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2017.07.129_bib0035","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2017.07.129_bib0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2014.06.030","article-title":"Interplay of oxidative, nitrosative\/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy","volume":"1852","author":"Varga","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.07.129_bib0045","doi-asserted-by":"crossref","first-page":"44239","DOI":"10.1038\/srep44239","article-title":"Myricitrin alleviates oxidative stress-induced inflammation and apoptosis and protects mice against diabetic cardiomyopathy","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.07.129_bib0050","first-page":"247","article-title":"Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis redox imbalance, metabolic changes and inflammation","volume":"2","author":"El-Missiry","year":"2015","journal-title":"Egypt J. Basic Appl. Sci."},{"key":"10.1016\/j.biopha.2017.07.129_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12933-016-0383-8","article-title":"Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway","volume":"15","author":"Korkmaz-Ic\u00f6z","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.taap.2012.12.005","article-title":"D-Saccharic acid 1, 4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-\u03baB and PKC signaling","volume":"267","author":"Bhattacharya","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-12-50","article-title":"Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy","volume":"12","author":"Wen","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/diseases4030024","article-title":"The protective effect of antioxidants consumption on diabetes and vascular complications","volume":"4","author":"Dal","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.biopha.2017.07.129_bib0075","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.3390\/nu7075230","article-title":"Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome","volume":"7","author":"Legeay","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2017.07.129_bib0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jtemb.2014.08.015","article-title":"Epigallocatechin gallate potentially attenuates fluoride induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats","volume":"29","author":"Miltonprabu","year":"2015","journal-title":"J. Trace. Elem. Med. Biol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2016.11.014","article-title":"Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction","volume":"794","author":"Othman","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bcp.2015.02.006","article-title":"Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: a mechanistic study","volume":"95","author":"Saeed","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408690390826464","article-title":"Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions","volume":"43","author":"Higdon","year":"2003","journal-title":"Crit. Rev. Food. Sci. Nutr."},{"key":"10.1016\/j.biopha.2017.07.129_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.diabres.2011.03.036","article-title":"Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo","volume":"93","author":"Li","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2017.07.129_bib0105","first-page":"305","article-title":"Epigallocatechin-3-gallate attenuates myocardial reperfusion injury in rats through activation of PI3K\/Akt signaling pathway","volume":"47","author":"Hu","year":"2016","journal-title":"Sichuan. Da. Xue. Xue. Bao. Yi. Xue. Ban."},{"key":"10.1016\/j.biopha.2017.07.129_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/etm.2014.2135","article-title":"Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats","volume":"9","author":"Zhong","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2017.07.129_bib0115","first-page":"3312","article-title":"Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals","volume":"9","author":"Chow","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2017.07.129_bib0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cbi.2013.02.006","article-title":"Oral L-glutamine increases active GLP-1 (7\u201336) amide secretion and improves glycemic control in stretpozotocin\u2013nicotinamide induced diabetic rats","volume":"203","author":"Badole","year":"2013","journal-title":"Chem. Biol. Interact"},{"key":"10.1016\/j.biopha.2017.07.129_bib0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/diab.47.2.224","article-title":"Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide","volume":"47","author":"Masiello","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2017.07.129_bib0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.cbi.2008.11.008","article-title":"Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin\u2013nicotinamide-induced diabetic rats","volume":"179","author":"Palsamy","year":"2009","journal-title":"Chem. Biol. Interact"},{"key":"10.1016\/j.biopha.2017.07.129_bib0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/ebm.2012.011372","article-title":"Streptozotocin?nicotinamide-induced diabetes in the rat. Characteristics of the experimental model","volume":"237","author":"Szkudelski","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2017.07.129_bib0140","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2013)\u2010epigallocatechin\u20103\u2010gallate prevents N\u2010methyl\u20104\u2010phenyl\u20101, 2, 3, 6\u2010tetrahydropyridine\u2010induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijdevneu.2007.12.003","article-title":"Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (\u2212)-epigallocatechin-3-gallate","volume":"26","author":"Srividhya","year":"2008","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2017.07.129_bib0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2017.07.129_bib0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0165","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nprot.2009.143","article-title":"Expression, purification and use of recombinant annexin V for the detection of apoptotic cells","volume":"4","author":"Logue","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2017.07.129_bib0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2017.07.129_bib0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2017.07.129_bib0180","first-page":"291","article-title":"The single cell gel assay: a sensitive technique for evaluating intercellular differences in DNA damage and repair","volume":"53","author":"Tice","year":"1990","journal-title":"Basic Life Sci."},{"key":"10.1016\/j.biopha.2017.07.129_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0190","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.acthis.2014.07.003","article-title":"Protective effects of epigallocatechin gallate (EGCG) on streptozotocin-induced diabetic nephropathy in mice","volume":"116","author":"Yoon","year":"2014","journal-title":"Acta Histochem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0195","first-page":"2016","article-title":"Epigallocatechin-3-gallate attenuates renal damage by suppressing oxidative stress in diabetic db\/db mice","author":"Yang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.07.129_bib0200","doi-asserted-by":"crossref","first-page":"30143","DOI":"10.1074\/jbc.M702390200","article-title":"Epigallocatechin-3-gallate (EGCG) a green tea polyphenol, suppresses hepatic gluconeogenesis through 5\u2032-AMP-activated protein kinase","volume":"282","author":"Collins","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0205","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/jf0006832","article-title":"Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism","volume":"48","author":"Kobayashi","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0210","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1055\/s-2004-832659","article-title":"Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo","volume":"70","author":"Koyama","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2017.07.129_bib0215","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.freeradbiomed.2012.01.033","article-title":"Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress","volume":"52","author":"Yan","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2017.07.129_bib0220","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.biopha.2017.07.129_bib0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1017\/S0007114511003758","article-title":"Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes","volume":"107","author":"Goto","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2017.07.129_bib0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0955-2863(03)00054-8","article-title":"Effect of EGCG on lipid absorption and plasma lipid levels in rats","volume":"14","author":"Raederstorff","year":"2003","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0235","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jnutbio.2011.03.014","article-title":"Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto\u2013Kakizaki (GK) rats: ameliorating effects of (\u2212)-epigallocatechin-3-gallate","volume":"23","author":"Yan","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.biopha.2008.02.002","article-title":"Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid","volume":"62","author":"Ran","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2017.07.129_bib0245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0973-1296.111287","article-title":"Cardioprotective effect of vedic guard against doxorubicin-induced cardiotoxicity in rats: a biochemical, electrocardiographic, and histopathological study","volume":"9","author":"Koti","year":"2013","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.biopha.2017.07.129_bib0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1211\/jpp.60.1.0016","article-title":"(\u2014)-Epigallocatechin gallate (EGCG) prevents isoprenaline-induced cardiac toxicity by stabilizing cardiac marker enzymes and membrane-bound ATPases","volume":"60","author":"Devika","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0255","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1021\/jf401635w","article-title":"Dietary supplementation with (\u2212)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (Gk) rats","volume":"61","author":"Uchiyama","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0260","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2004.02.099","article-title":"The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells","volume":"316","author":"Ludwig","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.07.129_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm3999","article-title":"Live to die another way: modes of programmed cell death and the signals emanating from dying cells","volume":"16","author":"Fuchs","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2017.07.129_bib0270","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbabio.2006.03.016","article-title":"Multiple pathways of cytochrome c release from mitochondria in apoptosis","volume":"1757","author":"Gogvadze","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2017.07.129_bib0275","doi-asserted-by":"crossref","first-page":"29296","DOI":"10.1074\/jbc.M702853200","article-title":"Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria","volume":"282","author":"Zimmermann","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.07.129_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrgentox.2013.04.022","article-title":"Assessment of DNA damage and lipid peroxidation in diabetic mice: effects of propolis and epigallocatechin gallate (EGCG)","volume":"757","author":"Or\u0161oli\u0107","year":"2013","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.biopha.2017.07.129_bib0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1745-7254.2007.00495.x","article-title":"EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats","volume":"28","author":"Sheng","year":"2007","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217319649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217319649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:24:32Z","timestamp":1776381872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217319649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":57,"alternative-id":["S0753332217319649"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.07.129","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.07.129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}